Trial

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Telepanel

Rank: Treasurer [?]

Points: 1140 [?]

Votes: 22 Score: 2.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Trial

posted on Nov 21, 2019 12:54PM

Bear did you see they have extended the Prostate trial for those that benefited from the drug as of Nov 11th till 2022

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply